Autizmus spektrumzavar: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• PTEN 2
• mTOR 0
• BDNF 0
• NMDA 0
• CTNNB1 1
• SCN2A 1
• AKT 0
• PI3K 0
• PPAR 0
• NRF2 0
• IL-6 0
• IL-17 0
• JAK 0
• NF1 0
• STAT3 0
• ERK 0
• NLRP3 0
• TREM2 0
• AMPK 0
• BCL-2 0
• DMD 0
• FTO 0
• IL-1 0
• SIRT1 0
• TLR4 0
• TP53 0
• APOE 0
• CD38 0
• CFTR 0
• COX-2 0
• G6PD 0
• GLP-1 0
• HDAC 0
• HER2 0
• HIF-1 0
• HMGB1 0
• KMT2A 0
• MAPK 0
• MMP-9 0
• PDGFR 0
• PKD1 0
• RANKL 0
• SCN1A 0
• TDP-43 0
• TNF 0
• VEGF 0

2559 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIMH · F31

  Cerebellar GABAergic Perturbation in a NDD Mouse Model

  University of California at Davis· Davis, Egyesült Államok· 43 749 USD awarded in fiscal year 2026· until 2028. okt.

• NIH NIMH · F31

  The role of the default mode network in representing and remembering mental states

  Boston College· Chestnut Hill, Egyesült Államok· 35 733 USD awarded in fiscal year 2026· until 2028. okt.

• NIH NEI · F31

  Molecular mechanisms and neural impact of human microglia immune tolerance

  Baylor College of Medicine· Houston, Egyesült Államok· 50 114 USD awarded in fiscal year 2026· until 2029. szept.

• NIH NINDS · R56

  Nuclear Factor One (NF1) gene regulation of cortical development

  Washington University· Saint Louis, Egyesült Államok· 544 250 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIAMS · R01

  Fmr1 and the regulation of osteoblast to osteocyte differentiation and bone mass and strength

  Indiana University Indianapolis· Indianapolis, Egyesült Államok· 452 938 USD awarded in fiscal year 2026· until 2031. júl.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  SYmbiotic Microbiota of honey Bees: Influence On Social communication (SYMBIOS)

  Universite de Geneve· Geneve, Svájc· EU contribution 307 959 EUR· until 2029. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Simulating Other Minds in Autism (MINDSIM)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 500 000 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  DEcoding Contextual Inference of Priors in Human pERception (DECIPHER)

  Universita Degli Studi di Firenze· Florence, Olaszország· EU contribution 317 923 EUR· until 2029. okt.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  High-throughput screen for disfunctions in GABA-switch in human neuronal models of SNAREopathies

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2028. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Tuning claustrum circuits to restore cognitive function (CLAUSTUNE)

  Universite de Geneve· Geneve, Svájc· EU contribution 150 000 EUR· until 2028. márc.

  The disease is named only in the funder's project summary, not in the title.

10 of 1705 running projects, newest first. Listed amounts together: 988,8 M USD + 166,0 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Leállították

  Effects of Lactobacillus Plantarum PS128 in Children With ASD

  NCT05307744· Chang Gung Memorial Hospital· Frissítve: 2026. okt. 6.

  “During COVID-19, study execution and participant compliance were significantly impacted. Lengthy procedures reduced parental and child willingness, causing slow recruitment. Due to these operational challenges, the study was terminated early.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

  NCT07329673· Qbtech AB· Frissítve: 2026. szept. 25.

  “Enrollment/study activities have been temporarily suspended while the sponsor evaluates internal study priorities and resource allocation. The suspension is not related to participant safety, protocol compliance, data quality, or regulatory concerns.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Frissítve: 2026. szept. 21.

  “Administrative”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Expediting Access to Services for Equity

  NCT06291246· University of North Carolina, Chapel Hill· Frissítve: 2026. júl. 10.

  “Study was prematurely terminated by funder.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Brain and Oculometric Markers of Emotional Facial Expression Recognition Deficits

  NCT05501405· Hôpital le Vinatier· Frissítve: 2026. jún. 12.

  “Investigator départure No analysis will be carried out”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Sensory Habituation in Autism Spectrum Disorders

  NCT06247176· University of Nebraska· Frissítve: 2026. máj. 29.

  “PI no longer at institution.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Milieu Teaching-AV (MT-AV Pilot)

  NCT06794476· Father Flanagan's Boys' Home· Frissítve: 2026. márc. 24.

  “Investigator left Vanderbilt University Medical Center and trial had not yet enrolled any participants.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions

  NCT03553875· Massachusetts General Hospital· Frissítve: 2026. febr. 25.

  “requested by the IRB”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Effectiveness Trial of Mobile ESI for Toddlers With Autism Identified by Early Screening in Primary Care

  NCT05456139· Florida State University· Frissítve: 2026. febr. 17.

  “NIMH determined that the grant was not feasible due to lack of sufficient participant recruitment and negotiated a bilateral termination of this grant on 04/01/2025. Recruitment was halted and an orderly phase-out plan was approved and implemented.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Vagus Nerve Stimulator for Autism and Other Developmental Disorders

  NCT06259201· New York State Institute for Basic Research· Frissítve: 2026. febr. 13.

  “Investigator decided to terminate the study - no participant enrolled.”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Evaluation of the TAP-Preschool (TAP-P) for Tele-assessment of Autism in Preschool-aged Children

  NCT07932665· Vanderbilt University Medical Center· Forrás

• Omic Profile in Autism Spectrum Disorder: From Cellular Level Towards Future Treatments

  NCT07427940· Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta· Forrás

• A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism

  NCT07284745· Bristol-Myers Squibb· Forrás

• A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

  NCT07285798· Bristol-Myers Squibb· Forrás

• A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  NCT07424404· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

  NCT06386029· University of Pittsburgh· Forrás

• Testing Design Thinking Methodology to Engage Hispanic and Latino Families of Autistic Children in Research.

  NCT06111092· Thomas Jefferson University· Forrás

• Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism

  NCT03583684· Stanford University· Forrás

• Speech-in-noise Perception in Autism and Fragile X

  NCT06088589· Children's Hospital Medical Center, Cincinnati· Forrás

• Assessment of self-perceived stress and repetitive behaviors after six weeks of daily intranasal oxytocin administration versus placebo: a randomised, multicentre, parallel group pragmatic trial in 210 men and women with autism

  2025-524797-42-00· UZ Leuven· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 16
• Organoids 21
• Mendelian Randomization Analysis 26
• CRISPR-Cas Systems 8
• Gene Expression Profiling 44
• Sequence Analysis, RNA 3
• Whole Genome Sequencing 7
• Exome Sequencing 52
• Proteomics 26
• Metabolomics 20
• Mass Spectrometry 7
• Immunohistochemistry 4
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 239
• Machine Learning 80
• Deep Learning 37
• Cohort Studies 134
• Genome-Wide Association Study 52

• CRISPR-Enabled functional genomics in hPSCs-derived neural models for autism spectrum disorder.

  Metab Brain Dis, 2026. szept.

• Modeling NDD-Associated NLGN2 Depletion Using CRISPR/Cas13 Reveals Exaggerated Process Elongation Mediated by the CCDC88A-G Protein-ELMO Axis.

  Int J Mol Sci, 2026. aug.

• A massively parallel CRISPR-based screening platform for modifiers of neuronal depolarization.

  Nat Commun, 2026. aug.

• CRISPR-engineered deletion of POGZ alters transcription factor binding at promoters of genes involved in synaptic signaling.

  HGG Adv, 2026. júl.

• Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation.

  Cells, 2026. ápr.

• A novel rat model harboring two BDNF gene mutations exhibiting autism-like behaviors and cognitive impairments.

  Neuropharmacology, 2026. márc.

• Isogenic modeling of 1q21.1 reciprocal CNVs in human ES cells reveals divergent neurodevelopmental trajectories.

  Hum Mol Genet, 2026. febr.

• Developmental convergence and divergence in human stem cell models of autism.

  Nature, 2026. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.